Dermapharm Makes Changes To Turn Around Arkopharma’s Performance

Intensified competition in the dietary supplements market and consumers squeezed by cost-of-living pressures held back sales at Dermapharm's Arkopharma subsidiary in the first half. A leadership change, along with a renewed focus on commercial excellence, is hoped by Dermapharm to turn the business around.

Germany’s Dermapharm Holding SE is hoping a leadership change will help turn around the fortunes of its French subsidiary Arkopharma.

Reporting its first half results, Dermapharm said Arkopharma’s sales had declined in the six months with the business facing intensified...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Earnings

More from Leadership